In different tumor cells, TREM2 expression levels vary significantly and can promote or inhibit tumor progression through different signaling pathways, such as NF-κB, JAK/STAT3 and PI3K/Akt signaling pathways. This evidence concerns the gene AKT1 and neoplasm.